Assays of Serum Testosterone

被引：19

作者：

Herati, Amin S. ^{[1
]}

Cengiz, Cenk ^{[1
]}

Lamb, Dolores J. ^{[1
,2
]}

机构：

[1] Baylor Coll Med, Scott Dept Urol, Ctr Reprod Med, 1 Baylor Plaza,Suite N730, Houston, TX 77030 USA

[2] Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA

来源：

UROLOGIC CLINICS OF NORTH AMERICA | 2016年 / 43卷 / 02期

关键词：

Adult; Humans; Testosterone/blood; Steroids/blood; Circadian rhythm; Hypogonadism/metabolism; Testosterone/deficiency; Immunoassay; TANDEM MASS-SPECTROMETRY; HORMONE-BINDING GLOBULIN; BIOAVAILABLE TESTOSTERONE; ANDROGEN DEFICIENCY; PLASMA TESTOSTERONE; BOUND TESTOSTERONE; NORMAL WOMEN; OLDER MEN; VALIDATION; DIHYDROTESTOSTERONE;

D O I：

10.1016/j.ucl.2016.01.003

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

The diagnosis of male hypogonadism depends on an assessment of the clinical signs and symptoms of hypogonadism and serum testosterone level. Current clinical laboratory testosterone assay platforms include immunoassays and mass spectrometry. Despite significant advances to improve the accuracy and precision of the currently available assays, limited comparability exists between assays at the lower and upper extremes of the testosterone range. Because of this lack of comparability, there is no current gold standard assay for the assessment of total testosterone levels.

引用

页码：177 / +

页数：9

共 56 条

[1]

[Anonymous], 2011, GLOB HLTH AG

[2] Prevalence of symptomatic androgen deficiency in men [J].